Form 4: DaVita Inc. Executive Waters Reports Stock Transactions

Kathleen Waters, Chief Legal & Public Affairs Officer of DaVita Inc., reports acquisition of stock appreciation rights and disposition of common stock to cover tax obligations.

Summary

• On March 15, 2025, Kathleen Waters, Chief Legal & Public Affairs Officer of DaVita Inc., reported transactions involving DaVita Inc. common stock.
• Waters acquired 3,346 shares of common stock at $0 and disposed of 2,759, 2,685, 955 and 939 shares at $143.45 to satisfy tax withholding obligations.
• She also acquired 9,263 stock appreciation rights (SARs) with an exercise price of $143.45, vesting in two tranches on March 15, 2028 and March 15, 2029, and expiring on March 15, 2030.
• Following these transactions, Waters directly owns 97,754 shares of common stock and 9,263 stock appreciation rights.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation and tax obligations, with no clear positive or negative implications for the company's outlook.

Positives

• The acquisition of stock appreciation rights indicates a potential belief in the future appreciation of DaVita's stock price.

Negatives

• The disposition of shares to cover tax obligations, while common, reduces the executive's direct holdings in the company.

Risks

• The value of the stock appreciation rights is dependent on the future performance of DaVita's stock price.
• Changes in tax laws could impact the attractiveness of equity-based compensation.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the stock appreciation rights and restricted stock units suggests a long-term incentive structure for the reporting person.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Equity compensation is a standard practice among publicly traded companies like DaVita, used to align the interests of executives with those of shareholders.
• Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize stock options and restricted stock units as part of their executive compensation packages.
• The vesting schedules and terms of these equity awards are generally comparable across the healthcare industry, with vesting periods typically ranging from three to five years.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they primarily relate to executive compensation and tax obligations.
• Shareholders may view the transactions as part of the company's efforts to align management's interests with their own.

Key Dates